Strategic alliances between corporations and non-profit medical clinical/research institutions are in the process of revitalizing healthcare. Fueled by the NIH’s support for translational science and the need for companies to cost-efficiently innovate and replenish their pipelines, these partnerships are intended to help researchers and clinicians quickly and effectively move discoveries “from the bench to the bedside.” Additionally, these alliances introduce a new generation of diagnostics, drugs and medical devices for the world’s populations.
Productive and successful alliances in clinical translational research are becoming essential for all organizations to remain in the forefront of medical innovation and patient care. However, these alliances require enterprise-wide analyses that are different from those used in traditional corporate sponsored research or technology transfer programs. Many organizational policies, procedures and practices are ill-equipped to address the shifting risks and rewards as research moves from lab to clinic to patient.
Uncovering the range of strategic, business and legal implications before entering these alliances is crucial to achieve successful partnerships.
Our Translational Science Team has the expertise and experience to provide your organization with an unparalleled range of services including:
- Alliance Formation, Origination and Negotiation
- Board Level Strategy and Policy Formulation
- Corporate Governance
- Conflicts of Interest
- Financial Viability Assessment
- Intellectual Property Policy and Management
- Regulatory Compliance
- Tax Matters
- Technology Transfer